updat confirm signific impact
tuesday close quest issu confirm compani seen signific impact
realiti believ other brace specif compani disclos oper result
januari februari ere consist ith prior guidanc said compani experienc materi declin volum
month march due pandem last two week march quest state volum declin
excess inclus test compani attribut eak government polici design reduc
transmiss hich led signific reduct volum quest ad possibl compani ill experi
advers impact cash collect result pandem
quest also withdraw previous announc guidanc given time recoveri
compani control quest plan provid updat ith result schedul note share quest
ytd vs trade ep forecast
ob/gyn survey impact fairli close base case
remind proactiv updat compani model estim impact tool
dx pandem playbook favor tool new posit view
nation lab embed volum impact month march mid-may
basi model updat ob/gyn survey perform ob/gyn gaug impact
test volum ultim delay patient visit expect impact lab test ob/gyn
survey expect see averag declin offic visit month march hich expect roughli impact
lab test eak expect extend anoth month least model split differ build
impact hile possibl could catch-up outbreak conclud assum constraint
physician phlebotomist time could limit benefit believ conserv assum doesnt happen
also note patient ho remain healthi hile isol burnt less far deduct normal hich could
unexpect headw ind
quest state januari februari consist expect though materi declin march includ
last two week march depend magnitud impact first tw eek march believ
quarterli impact could close forecast maintain forecast quest
week begin see impact patient
visit offic
mani patient visit month march
delay april beyond due outbreak
lab test order past two week
rate lab test order chang versu
lab test order month
rate lab test order chang versu normal
market model test serv off-set built model year end
ultim quest confirm neg impact elect test delay greater posit impact
test remind base case assum labcorp quest could see posit revenu
impact test year end test market model lab assum base case market size
estim labcorp quest market share land around littl nation lab rough share
routin test market labcorp quest ere tw earli leader expand test capac thousand test
initi per day eek least per day today model assum quest labcorp volum
would top test per day quest disclos run test per day total industri test
capac top roughli test per day test capac scale believ much new capac ill come
lab decentr test capabl number point care option come market hich help speed
turnaround time patient test option could decentr hospit versu nation lab one point
could result nation lab consolid share test might run loss hospit might alreadi
financi pressur pandem ould easier outsourc test labcorp quest ith rel suffici
quest estim compani see net revenu headwind headwind ebit
impact pronounc assum quest headw ind volum month march
mid-may assum aforement posit test impact persist year end
altogeth lower revenu averag rais forecast given high increment
margin nation lab busi model assum averag impact adj ebit tailw ind
analysi prior estim updat
stress test estim upsid case scenario impact march mid-may
downsid case scenario impact mid-august downsid case scenario estim
earn impact quest
medicar rate updat delay
final note one long-last chang pandem playbook came fruition quickli part
congression stimulu packag schedul medicar cut postpon least languag
bill contain page around revis phase-in reduct privat payor rate implement cap
medicar reimburs reduct set vs reduct previous schedul get enact
cut simpli delay though hope lab one year postpon could ultim becom perman
addit delay reimburs reduct bill ould delay data report period laboratori next
survey new data collect period ould rate effect start
detail pleas see lab pama reimburs updat tool kit volume issu
clf medicar rate cut year
lab ep forecast without final pama
pleas reach us ith question thank
meehan cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens ill
directli indirectli relat specif recommend view express research report
barclay capit inc and/or one affili seek busi ith compani cover research report
result investor aw firm may conflict interest could affect object report investor
consid report singl factor make invest decis
barclay research produc invest bank barclay bank plc affili collect individu
barclay author contribut research report research analyst unless otherw ise indic public date
top report reflect local time report produc may differ releas date provid gmt
avail disclosur
 compani subject research report current import disclosur regard compani pleas
refer http //publicresearch barclay com altern send ritten request barclay research complianc seventh
avenu floor new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ
firm total revenu portion hich gener invest bank activ profit revenu market
busi potenti interest firm invest client research ith respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit
accept payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link
analysi quantit analysi trade idea recommend contain one type barclay research may differ
contain type barclay research hether result differ time horizon methodolog otherw ise
order access barclay statement regard research dissemin polici procedur pleas refer
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas
refer http //publicresearch barcap com/s/cm htm
master limit partnership mlp pass-through entiti structur publicli list partnership tax purpos
distribut unit holder may treat return princip investor consult ow tax advisor
invest unit
valuat methodolog price repres ep forecast
risk may imped achiev barclay research valuat price remain uncertainti
around protect access medicar act pama could impact reimburs clinic lab quest expos broader
macro trend around labor employ grow th hich could impact volum grow th addit half quest cost base
labor-rel hich creat exposur age grow th implement prefer lab netw ork potenti also alter
volum dynam betw een nation lab provid final exposur hich could disrupt
sale oper
rate price target histori
prior intra-day chang may publish rate secur equal eight
adjust price target
histor stock price price target may adjust stock split dividend
unless otherw ise indic price sourc bloomberg reflect close price relev trade market hich
may last avail price time public
